BioMatrix, Inc. - BIOX- Profile

Biomatrix, Inc., develops, manufactures, markets and sells a series of proprietary viscoelastic products called "hylans". Hylans are the second generation of viscoelastics used in medicine and are characterized by significantly enhanced physical properties such as elasticity, viscosity and pseudoplasticity. These products are used in therapeutic medical applications and skin care. The wide range of patented products are in the form of fluids, gels and solids. The company's operations consist of therapeutic medical products, skin care intermediate products and toxicity testing. Of late, a significant source of revenue has been from certain up-front payments relating to corporate license and distribution agreements. The company has operations in United Kingdom, Switzerland, Hong Kong, France, Germany and Belgium. On March 6, 2000, the company entered into an agreement and plan of merger with Genzyme Corporation. The company has incurred $0.3 million towards year 2000 expenses till date.